Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
P/OCF Ratio
-9.98×
TTM · Retrieved:
LCTX P/OCF Ratio
Current (TTM)-9.98×retrieved
Current (TTM)-9.98×retrieved
LCTX Quarterly P/OCF Ratio (0.00× → -45.12×)
Latest values, visible window
High-resolution chart · PNG
LCTX p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| -45.1192× | |
| -47.926× | |
| -78.781× | |
| -106.9584× | |
| -37.4093× | |
| -20.8936× | |
| -15.852× | |
| -29.5408× | |
| -34.8042× | |
| -46.178× | |
| -31.2681× | |
| -40.9657× | |
| -38.375× | |
| -22.6997× | |
| -23.9569× | |
| -35.0106× | |
| -37.8276× | |
| 11.9273× | |
| -69.9266× | |
| -87.1313× | |
| -83.9845× | |
| -50.243× | |
| -46.7918× | |
| -28.9797× | |
| -30.7488× | |
| -24.6827× | |
| -24.0205× | |
| -19.7052× | |
| -15.9377× | |
| -18.5446× | |
| -19.8832× | |
| -39.2817× | |
| -35.3187× | |
| -33.012× | |
| -47.333× | |
| -42.627× | |
| -36.8137× | |
| -45.4626× | |
| -41.9134× | |
| -44.9325× | |
| -23.7514× | |
| -18.0592× | |
| -26.5811× | |
| -20.1669× | |
| -28.5391× | |
| -42.89× | |
| -31.9184× | |
| -24.7738× | |
| -17.403× | |
| -18.5055× | |
| -23.4799× | |
| -32.9407× | |
| -29.8458× | |
| -27.7682× | |
| -30.9621× | |
| -42.3163× | |
| -58.7515× | |
| -37.8258× | |
| -81.3131× | |
| -59.9755× | |
| -89.619× | |
| -99.7615× | |
| -141.0749× | |
| -101.3569× | |
| -133.7249× | |
| -196.0066× | |
| -167.3052× | |
| -122.7423× | |
| -74.2085× | |
| -52.7893× | |
| -84.8214× | |
| -87.79× | |
| -27.7797× | |
| -25.5797× | |
| -26.6021× | |
| -47.6082× | |
| -29.3482× | |
| -33.3144× | |
| -32.1112× | |
| -19.9235× | |
| -55.3296× | |
| -11.7507× | |
| 19.9389× | |
| -11.6294× | |
| -23.3864× | |
| -30.6104× | |
| -136.0828× | |
| -105.5302× | |
| -77.7396× | |
| -38.6478× | |
| -48.3932× | |
| 43.7049× | |
| -169.9542× | |
| -37.4836× | |
| -41.0005× | |
| -32.5154× | |
| -51.463× | |
| -52.4346× | |
| -188.3145× | |
| -59.4966× |